Comments

Cara Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Cara Therapeutics (CARA) operate in?

Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CARANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$5.13

0.214.38%

At close: -

$4.01

-1.12-21.76%

After Hours: Mar 5, 8:26 AM EDT

Cara Therapeutics (CARA) Forecast

News Earnings Cara Therapeutics (CARA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cara Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CARA | Benzinga

Explore Cara Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CARA.

Open	$5.00
Close	$5.13
Volume / Avg.	12.77K / 129.36K
Day Range	$4.87 - $5.20
52 Wk Range	2.71 - 13.20
Market Cap	$18.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	1.69%
Days to Cover	3.39

Recent News

Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Cara Therapeutics Stock?

Cara Therapeutics shares are trading higher by 15% during Thursday's session. The company earlier announced it engaged Piper Sandler & Co. as a financial advisor to explore strategic alternatives.

Henry Khederian

S&P 500 Edges Higher; J.Jill Shares Plunge

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.00
Close	$5.13
Volume / Avg.	12.77K / 129.36K
Day Range	$4.87 - $5.20
52 Wk Range	2.71 - 13.20
Market Cap	$18.33M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	1.69%
Days to Cover	3.39

About Cara Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of no...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cara Therapeutics (CARA) stock?

You can purchase shares of Cara Therapeutics (NASDAQ:CARA) through any online brokerage.

View our list of the best stock brokerages

Who are Cara Therapeutics (CARA) competitors?

Other companies in Cara Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).

What is the forecast, or price target, for Cara Therapeutics (CARA) stock?

Cara Therapeutics has a consensus price target of $11.33.

What is the current price for Cara Therapeutics (CARA)?

The stock price for Cara Therapeutics (NASDAQ: CARA) is $4.01 last updated March 5, 2025 at 8:26 AM EST.

Does Cara Therapeutics (CARA) pay a dividend?

There are no upcoming dividends for Cara Therapeutics.

When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?

Cara Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Cara Therapeutics (CARA) going to split?

There is no upcoming split for Cara Therapeutics.

What sector and industry does Cara Therapeutics (CARA) operate in?

Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.